Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?
- PMID: 26857504
- DOI: 10.1016/j.jneuroim.2016.01.007
Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?
Abstract
Environmental factors are implicated in the development of Parkinson's disease (PD). We have investigated on the role of molecular mimicry between HSV1 and α-synuclein that could foster the progression of PD. The antibody response against homologous peptides in PD patients and healthy controls was evaluated, showing that these antibodies are highly prevalent among PD patients to healthy controls. The competitive assay demonstrated cross-reactivity between HSV1 and human α-synuclein peptides. The results may suggest the hypothesis of the involvement of HSV1 in stimulating the immune cells against the neurons of the substantia nigra as a consequence of the cross reactivity.
Keywords: Autoimmunity; Cross-reactivity; HSV1; Parkinson's disease; α-Synuclein.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6. Brain. 2005. PMID: 16000336
-
Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3. Mov Disord. 2014. PMID: 24996051
-
Homologous HSV1 and alpha-synuclein peptides stimulate a T cell response in Parkinson's disease.J Neuroimmunol. 2017 Sep 15;310:26-31. doi: 10.1016/j.jneuroim.2017.06.004. Epub 2017 Jun 15. J Neuroimmunol. 2017. PMID: 28778441
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
-
Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.Acta Neuropathol. 2006 Aug;112(2):115-26. doi: 10.1007/s00401-006-0096-2. Epub 2006 Jun 22. Acta Neuropathol. 2006. PMID: 16791599 Review.
Cited by
-
Biomolecular Changes and Cortical Neurodegenerative Lesions in Trichinella Spiralis Infected BALB/c Mice: A Preliminary Study Elucidating a Potential Relationship Between Systemic Helminthic Infections and Idiopathic Parkinson's.Helminthologia. 2018 Oct 27;55(4):261-274. doi: 10.2478/helm-2018-0029. eCollection 2018 Dec. Helminthologia. 2018. PMID: 31662657 Free PMC article.
-
Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.Mov Disord. 2021 Jan;36(1):25-36. doi: 10.1002/mds.28411. Epub 2020 Dec 14. Mov Disord. 2021. PMID: 33314312 Free PMC article. Review.
-
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases.Theranostics. 2022 Mar 28;12(7):3045-3056. doi: 10.7150/thno.72126. eCollection 2022. Theranostics. 2022. PMID: 35547759 Free PMC article. Review.
-
Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation.Biomedicines. 2021 Nov 9;9(11):1648. doi: 10.3390/biomedicines9111648. Biomedicines. 2021. PMID: 34829877 Free PMC article. Review.
-
Rehabilitation for non-motor symptoms for patients with Parkinson's disease from an α-synuclein perspective: a narrative review.Explor Neuroprotective Ther. 2023;3(4):235-257. doi: 10.37349/ent.2023.00049. Epub 2023 Aug 27. Explor Neuroprotective Ther. 2023. PMID: 37920444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous